Fulvestrant in treatment for metastatic breast cancer

Background. Metastatic breast cancer is still an incurable disease, and is currently regarded as a chronic process requiring longterm treatment with periodic therapy replacements. Hormonal therapy shows its therapeutic efficacy with less toxicity and a better quality of life for patients compared wi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, A. E. Storozhakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. L’yanova, L. A. Ryadinskaya, M. O. Ezhova, M. A. Teplyakova, L. K. Strakhov
Format: Artigo
Jezik:Russo
Izdano: Remedium Group LLC 2019-12-01
Serija:Медицинский совет
Teme:
metastatic hormone-positive breast cancer
fulvestrant
hormonal therapy
adverse events
toxicity
Online pristup:https://www.med-sovet.pro/jour/article/view/5157
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items